Letter: Augmenting cryoprecipitate factor VIII activity.
D011232:Chemical Precipitation; D003365:Costs and Cost Analysis; D003450:Cryoglobulins / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans
D003450:Cryoglobulins; D005169:Factor VIII